[Irritable bowel syndrome: the next-to-last that is being investigated]

Med Clin (Barc). 2016 Mar 18;146(6):260-2. doi: 10.1016/j.medcli.2015.10.010. Epub 2015 Dec 2.
[Article in Spanish]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antidepressive Agents, Tricyclic / therapeutic use
  • Biomarkers
  • Complementary Therapies
  • Diet / adverse effects
  • Dietary Carbohydrates / adverse effects
  • Fecal Microbiota Transplantation
  • Fermentation
  • Humans
  • Irritable Bowel Syndrome* / etiology
  • Irritable Bowel Syndrome* / immunology
  • Irritable Bowel Syndrome* / metabolism
  • Irritable Bowel Syndrome* / therapy
  • Melatonin / therapeutic use
  • Peptides / therapeutic use
  • Probiotics / therapeutic use

Substances

  • Antidepressive Agents, Tricyclic
  • Biomarkers
  • Dietary Carbohydrates
  • Peptides
  • Melatonin
  • linaclotide